UiPath (NYSE:PATH) Announces Quarterly Earnings Results

UiPath (NYSE:PATH) issued its quarterly earnings data on Thursday. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01, Briefing.com reports. The company had revenue of $316.00 million during the quarter, compared to analysts’ expectations of $303.69 million. UiPath had a negative return on equity of 2.97% and a negative net margin of 6.41%. The business’s revenue was up 10.0% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.09) earnings per share. UiPath updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

UiPath Stock Performance

NYSE:PATH traded down $0.77 during trading hours on Friday, reaching $11.97. The company’s stock had a trading volume of 38,813,948 shares, compared to its average volume of 10,047,398. The firm has a 50-day simple moving average of $12.20 and a 200-day simple moving average of $16.71. UiPath has a 1 year low of $10.37 and a 1 year high of $27.87. The firm has a market capitalization of $6.86 billion, a price-to-earnings ratio of -74.84 and a beta of 0.87.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PATH. Canaccord Genuity Group cut their price target on UiPath from $30.00 to $19.00 and set a “buy” rating for the company in a research note on Friday, May 31st. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $16.00 price target on shares of UiPath in a research note on Friday. JPMorgan Chase & Co. decreased their target price on shares of UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Scotiabank dropped their price objective on UiPath from $30.00 to $25.00 and set a “sector perform” rating on the stock in a research note on Wednesday, May 29th. Finally, William Blair downgraded shares of UiPath from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $17.71.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.